Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Press release

BioGaia launches a probiotic food supplement for women before and during pregnancy

BioGaia

Prenatal Care is a probiotic food supplement that contains BioGaia's patented bacteria strain L. reuteri DSM 17938 along with folic acid, iron, and vitamin D\3\, for expecting mothers as well as women planning to conceive.

Besides BioGaia's patented bacterial strain L. reuteri DSM 17938, one of the most scientifically well-documented probiotic strains in terms of efficacy and safety, Prenatal Care contains folic acid, iron and vitamin D\3\. Folic acid can support the neural tube development of the growing foetus. Iron contributes to the normal formation of red blood cells and haemoglobin and reduces fatigue and tiredness, and vitamin D can support the immune system.

"BioGaia sought to offer women a supplement that contains good bacteria, mineral and vitamins before and during their pregnancy. We know through consumer insights that women planning to conceive or who are pregnant seek safe, trustworthy, and convenient products. And Prenatal Care is the product for them", says Isabelle Ducellier, CEO at BioGaia.
The launch of Prenatal Care is planned in Sweden in Q4, 2023.
Safe to use
L. reuteri DSM 17938 is clinically tested and safe to use for the mother and the foetus.
 

Follow us:
Subscribe to BioGaia press releases here (https://www.biogaia.com/press/subscribe-to-press-releases/)
LinkedIn here (https://www.linkedin.com/company/biogaia-ab/)

Contacts:
Mikaela Idermark Stern, Corporate Communications
Email: mis@biogaia.se
Phone: +46 730 95 61 50

About BioGaia
BioGaia is an innovative Swedish healthcare company that develops, markets, and sells probiotic products with documented health benefits. The products are sold through local distribution partners or via own distribution in over 100 markets. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. biogaia.com (https://www.biogaia.com/)

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.